June 21, 2017 / 1:58 PM / 2 months ago

BRIEF-U.S. FDA says it is working to lift barriers to generic drug competition

June 21 (Reuters) - U.S. FDA :

* U.S. FDA's Scott Gottlieb says FDA working to lift barriers to generic drug competition

* U.S. FDA's Gottlieb says while FDA doesn’t have a direct role in drug pricing, it can take steps to help address this problem

* U.S. FDA's Gottlieb says FDA can take steps to address pricing problem by facilitating increased competition through approval of lower-cost, generic medicines

* U.S. FDA's Gottlieb says it is working on a drug competition action plan Source text : (bit.ly/2rCuPO2)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below